View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
January 19, 2022

BiologyWorks’ trial of Covid-19 test matches lab results accuracy

The device provides results to patients and POC providers simultaneously in 45 minutes.

Digital healthcare platform firm BiologyWorks has announced that its k(now) handheld molecular testing device showed 99.1% accuracy with RT-PCR lab test results in a substantive Covid-19 clinical trial.

Conducted by Locus Medicus in Athens, Greece, the independent clinical study tested 330 asymptomatic and symptomatic Covid-19 patients.

The clinical laboratory staff collected two bilateral anterior nasal swabs from each patient for the trial.

One swab was tested in the handheld, reusable molecular test while the standard of care CE-Mark RT-PCR lab test was used for the other.

Findings showed that the molecular testing device was 99.1% accurate with the laboratory RT-PCR test results.

BiologyWorks k(now) molecular Covid-19 test is connected with the k(now) PRO digital platform, which provides a complete solution to point-of-care (POC) providers for end-to-end testing management.

The device provides results to patients and POC providers simultaneously in 45 minutes.

The company stated that the Los Angeles County Department of Health Services, the University of California Los Angeles (UCLA) and Streeklab in Haarlem, Netherlands, have also conducted independent studies on the BiologyWorks k(now).

Additionally, the molecular testing device’s efficacy was verified with more than 12,000 tests in the company’s Southern California laboratory.

All these studies confirmed that the device provides laboratory RT-PCR quality results.

BiologyWorks CEO Hunt Ramsbottom said: “Our company’s priority is to make lab-quality testing accessible, accurate and affordable for everyone.

“These clinical trials confirm that our handheld, reusable test is among the most accurate for Covid-19.

“We give individuals and providers a highly reliable testing platform, with significantly lower cost per result and shortened time to results.”

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network